Helene D. Gayle - 14 Sep 2021 Form 4 Insider Report for GoHealth, Inc. (GOCO)

Reporting relationship: Director
Issuer ticker: GOCO
Reported as of: 14 Sep 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Sep 2021, 17:25:03 UTC
Prior SEC filing: 08 Jun 2021
Next SEC filing: 05 Apr 2022
Source filing: View source filing
Reporting owner signature: /s/ Travis J. Matthiesen, Attorney-in-fact for Helene G. Gayle

Key filing fact

Helene D. Gayle filed Form 4 for GoHealth, Inc. (GOCO) on 16 Sep 2021.

Key facts

This page summarizes Helene D. Gayle's Form 4 filing for GoHealth, Inc. (GOCO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 Sep 2021, 17:25.

Change

Previous filing in this sequence was filed on 08 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GOCO transaction Derivative

Deferred Stock Units

Award

Transaction value: $0
Shares: +5,688
Change %: +80%
Price: $0.000000
Shares after: 12,831
Date: 14 Sep 2021
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 5,688
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each deferred stock unit represents the right to receive one share of Class A common stock of the Issuer.

Footnote F2

The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on December 14, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.